This Roundtable will discuss:
Our industry is changing so rapidly, it can be hard to stay on top of what’s coming next. From the impending enforcement of EU-CTR (EU Clinical Trial Regulation) to the increased attention on safely sharing clinical trial data as a way to drive pharmaceutical innovation, you need to start planning ahead.
In this roundtable, we’ll hear from industry insiders as they share their insights into three key trends for 2022. Each segment will include an opportunity for participants to engage in an interactive discussion on the importance of each trend as trial sponsors prepare for the year ahead.
Trend 1: Re-Using Clinical Trial Data for Innovation
(Introduced by Aaron Mann, Senior Vice President, Data Science, Clinical Research Data Sharing Alliance)
Trend 2: Turning Clinical Trial Documents into Insight with NLP
(Introduced by Jane Reed, Director, Life Sciences, Linguamatics)
Trend 3: Considerations for EU-CTR and EMA Policy 0070
(Introduced by Vivien Fagan, Director, Global Medical Writing, IQVIA)
Learning Objectives
After this session, you should be able to:
- Recognize upcoming trends in Clinical Trial Transparency to proactively position your organization to adapt and lead.
- Demonstrate increased value from clinical trial data to internal stakeholders by staying on top of industry trends.
- Identify best practices in promoting Clinical Trial Transparency while protecting individual privacy.
Please note that this is an exhibitor-sponsored event and is not eligible for CE credit.
Moderators:
 |
Sarah Lyons, Head of Privacy Analytics, Privacy Analytics | |
 |
Rebecca Li, PhD, Executive Director, Vivli, Center for Global Data Research |